Jefferies initiates coverage on Enel (OTC:ENLAY) with a Underperform rating.
Jefferies Initiates Coverage On Enel with Underperform Rating
Jefferies initiates coverage on Enel (OTC:ENLAY) with a Underperform rating.
Related Posts
Tataa Biocenter Is Partnering With Olink and Illumina to Offer High Performance Proteomics With Unprecedented Throughput
"Olink® EXPLORE 3072 is the perfect complement to our already optimized genomics and transcriptomics offerings and will be imperative in our services supporting the pharmaceutical industry," said Mikael Kubista, founder and CEO of Tataa Biocenter. "We already offer workflow optimization and validation including multiomics, and with this new platform, our capacity dramatically increases."
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
ONEOK (NYSE:OKE) has outperformed the market over the past 20 years by 2.28% on an annualized basis producing an average annual return of 9.13%. Currently, ONEOK has a market capitalization of $26.41 billion.
Analyst Ratings for Amedisys
Over the past 3 months, 5 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.